Akanda

AKAN

1.360102.47% ( +0.688 )

Closed: Nov 13, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -0.01, above the reasonable range, cheaper than 0% of the time in the past 3 years, and the industry ranks 68/257, the industry Median -0.97.

-0.0071xP/E

Stock price$0.67Earnings per share$-94.36

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

03774111148

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x20x40x60x80x100x

P/E ratio
Name/Symbol
BAYRYUSBayer	-37.04x	--	$61.58B
BAYZFUSBayer Aktiengesellschaft	-36.76x	--	$61.11B
VTRSUSViatris	-38.99x	97.55%	$23.70B
ELANUSElanco Animal Health	-90.10x	168.15%	$13.25B
ABVXUSAbivax SA	-16.91x	22.99%	$7.86B
AXSMUSAxsome Therap	-48.28x	29.75%	$7.59B
BLTEUSBelite Bio	-66.87x	28.79%	$6.84B
VREOFUSVIREO GROWTH INC	-97.56x	--	$6.42B
CURLFUSCuraleaf Holdings, Inc.	-298.92x	--	$6.17B
MANEUSVeraDermics	-55.03x	97.76%	$5.65B
LQDAUSLiquidia Tech	-55.60x	69.38%	$5.24B
DFTXUSDefinium Therapeutics	-13.39x	41.54%	$4.52B
AMLXUSAmylyx Pharmaceuticals	-23.52x	0.72%	$3.84B
TARSUSTarsus Pharmaceuticals	-5.40x	879.07%	$3.79B
ELVNUSEnliven Therapeutics	-31.33x	3.43%	$3.56B
BHCUSBausch Health	-3.67x	511.90%	$3.09B
XERSUSXeris Biopharma	-468.28x	--	$3.04B
MBXUSMBX Biosciences	-18.09x	52.01%	$2.63B
RGCUSRegencell Bioscience	-217.00x	--	$2.54B
PHVSUSPharvaris BV	-11.99x	16.90%	$2.38B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.